
Neuralink, founded by Elon Musk, has received the FDA's breakthrough device designation for its new Blindsight implant. The experimental brain chip aims to restore vision in individuals who have lost both eyes or their optic nerve function. The breakthrough designation helps accelerate the development of innovative devices like Blindsight, while Neuralink continues to test other implants designed to aid disabled patients with movement and communication.
Like
Save
Share